1. Home
  2. BLND vs AVDL Comparison

BLND vs AVDL Comparison

Compare BLND & AVDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLND
  • AVDL
  • Stock Information
  • Founded
  • BLND 2012
  • AVDL 2015
  • Country
  • BLND United States
  • AVDL Ireland
  • Employees
  • BLND N/A
  • AVDL N/A
  • Industry
  • BLND EDP Services
  • AVDL Biotechnology: Pharmaceutical Preparations
  • Sector
  • BLND Technology
  • AVDL Health Care
  • Exchange
  • BLND Nasdaq
  • AVDL Nasdaq
  • Market Cap
  • BLND 959.7M
  • AVDL 867.3M
  • IPO Year
  • BLND 2021
  • AVDL 1996
  • Fundamental
  • Price
  • BLND $3.78
  • AVDL $8.41
  • Analyst Decision
  • BLND Buy
  • AVDL Strong Buy
  • Analyst Count
  • BLND 8
  • AVDL 7
  • Target Price
  • BLND $4.86
  • AVDL $18.86
  • AVG Volume (30 Days)
  • BLND 2.1M
  • AVDL 1.3M
  • Earning Date
  • BLND 02-27-2025
  • AVDL 03-03-2025
  • Dividend Yield
  • BLND N/A
  • AVDL N/A
  • EPS Growth
  • BLND N/A
  • AVDL N/A
  • EPS
  • BLND N/A
  • AVDL N/A
  • Revenue
  • BLND $156,715,000.00
  • AVDL $138,160,000.00
  • Revenue This Year
  • BLND $5.35
  • AVDL $515.49
  • Revenue Next Year
  • BLND $20.75
  • AVDL $48.85
  • P/E Ratio
  • BLND N/A
  • AVDL N/A
  • Revenue Growth
  • BLND N/A
  • AVDL 1523.50
  • 52 Week Low
  • BLND $2.08
  • AVDL $7.39
  • 52 Week High
  • BLND $5.53
  • AVDL $19.09
  • Technical
  • Relative Strength Index (RSI)
  • BLND 43.82
  • AVDL 45.85
  • Support Level
  • BLND $3.59
  • AVDL $8.27
  • Resistance Level
  • BLND $4.08
  • AVDL $9.34
  • Average True Range (ATR)
  • BLND 0.19
  • AVDL 0.44
  • MACD
  • BLND 0.01
  • AVDL 0.09
  • Stochastic Oscillator
  • BLND 29.37
  • AVDL 43.29

About BLND Blend Labs Inc.

Blend Labs Inc is a cloud-based platform software platform that powers the digital interface between financial services firms and consumers. It supports and simplifies applications for mortgages, consumer loans, and deposit accounts. Its operating segments are; Blend Platform segment which comprises a suite of products that power the entire origination process from back-end workflows to consumer experience, and the Title segment enables customers to streamline the title, settlement, and closing process at scale for mortgages, home equity lines of credit, and home equity loans. The majority of the revenue for the company is generated from the Blend Platform segment.

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. It identifies, develops, and commercializes branded pharmaceutical products including controlled-release therapeutic products based on its proprietary drug delivery technologies in the United States. The company is engaged in development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy.

Share on Social Networks: